Evaluation of some essential element levels in thalassemia major patients in Mosul district, Iraq

Saudi Medical Journal

Volumn 29, Issue 1, 2008, Pages 94-97

  Al Samarrai, Abdulmunaim H ^a   Adaay, Mohaisen H ^b,c   Al Tikriti, Khudhair A ^a   Al Anzy, Muayed M ^a  

^a TIKRIT UNIVERSITY   (Iraq)

^b AL NAHRAIN UNIVERSITY   (Iraq)

^c SYRIAN PRIVATE UNIVERSITY   (Syrian Arab Republic)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; COPPER; MAGNESIUM; PHOSPHATE; POTASSIUM; SODIUM; ZINC; TRACE ELEMENT;

ADOLESCENT; ADULT; ARTICLE; BLOOD TRANSFUSION; CALCIUM BLOOD LEVEL; CHILD; CONTROLLED STUDY; COPPER BLOOD LEVEL; CORRELATION COEFFICIENT; FEMALE; HEMOCHROMATOSIS; HEMOLYSIS; HUMAN; HYPERNATREMIA; HYPOMAGNESEMIA; HYPOPARATHYROIDISM; INFECTION; IRAQ; KIDNEY INJURY; MAGNESIUM BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PHOSPHATE BLOOD LEVEL; POTASSIUM BLOOD LEVEL; SODIUM BLOOD LEVEL; STATISTICAL SIGNIFICANCE; TEACHING HOSPITAL; THALASSEMIA MAJOR; ZINC BLOOD LEVEL; ZINC DEFICIENCY; ZINC URINE LEVEL; BETA THALASSEMIA; BLOOD; CASE CONTROL STUDY; PRESCHOOL CHILD; PROSPECTIVE STUDY;

ADOLESCENT; BETA-THALASSEMIA; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; COPPER; FEMALE; HUMANS; IRAQ; MAGNESIUM; MALE; POTASSIUM; PROSPECTIVE STUDIES; TRACE ELEMENTS; ZINC;

EID: 40949130503     PISSN: 03795284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Olivieri NF. The beta-thalassaemia. N Engl J Med 1999; 341: 99-109.
2. Najdecki R, Georgiou I, Lolis D. The thalassemia syndromes and pregnancy, molecular basis, clinical aspects, prenatal diagnosis. Ginekol Pol 1998; 69: 664-668.
3. De Sanctis V. Pinamonti A, Di Palma A, Sprocati M, Atti G, Gamberini MR. Growth and development in thalassaemia major patients with severe bone lesions due to desferrioxamine. Eur J Pediatr 1996; 155: 368-372.
4. Low LC, Postel-Vinay MC, Kwan EY, Cheung PT. Serum growth hormone (GH) binding protein. IGF-I and IGFBP-3 in patients with beta-thalassaemia major and the effect of GH treatment. Clin Endocrinal (Oxf) 1998; 48: 641-646.
5. Soliman AT, elZalabany MM, Mazloum Y, Bedair SM, Ragab MS, Rogol AD, et al. Spontaneous and provoked growth hormone (GH) secretion and insulin-like growth factor I (IGF-1) concetration in patients with beta-thalassaemia and delayed growth, J Trop Pediatr 1999; 45: 327-337.
6. Labropoulou-Karatza C, Goritsas C, Fragopanagou H, Repandi M, Matsouka P, Alezabdrides T. High prevalence of diabetes mellitus among adult beta-thalassaemic patients with chronic hepatitis C. Eur J Gastersenterol Hepatol 1999; 11: 1033-1036.
7. Monge L, Pinach S, Canunellina L, Berrero MT, Dall'omo A, Carr Q. The possible role of autoimmunity in the pathogenesis of diabetes in beta-thalassaemia major. Diabetes Metab 2001; 27: 149-154.
8. Gulati R, Bhatia V, Agarwal SS. Early Onset of endocrine abnormalities in beta-thalassemia major in a developing country. J Pediatr Endocrinol Metab 2000; 13: 651-656.
9. Swasan S, Sarab H, Ali T. Iron overload and endocrine pattern in children with thalassemia syndromes. Iraqi J Medical Sciences 2001;1:159-168.
10. Al-Jumaili A, Khider S. Prevalence of hypocalcaemia among thalassemic patients and sicklers in thalassemic center in lbn Albalady hospital. Proceeding of the 1st Scientific Conference on thalassemia and hemoglobinapathies in Iraq. Mosul: University of Mosul Press: 2000, p. 28-30.
11. Cario H, Stahuke K, Kohne E. Beta-thalassemia in Germany. Results of cooparative beta- thalassemia study. Klin Pediatr 1999; 211: 431-437.
12. Ambu R, Crisponi G, Sciot R, Van Fyken P, Parado G, Iannelli S, et al. Uneven hepatic iron and phosphorus distribution in beta-thalassemia. J Hepatol 1995; 23: 544-549.
13. Karvounis HI, Zaglavara TA, Parharidis GE, Nouskas IG, Hassapopoulou EP, Gemitzis KD, et al. An angiotensin-converting enzyme inhibitor improves left ventricular systolic and diastolic function in transfusion-dependent patients with beta-thalassemia major. Am Heart J 2001; 141: 281.
14. Hahalis G, Manolis AS, Getasimidou I, Ioanna G, Alexopoulos D, Sitafidis G, Kourakli A, et al. Right ventricular diastolic function in [beta]-thalassemia major: Echocardiographic and clinical correlates. A Am Heart J 2001; 141: 428-434.
15. Arcasay A Cavdar AC, Cin S, Erten J, Babacan E, Gozdasoglu S, Akar N. Effects of zinc supplementation on linear growth in beta-thalassemia (A new 9 approach). Am J Hemat 1987; 24: 127-136.
16. Fuch GJ, Tienboon P, Linpisarn S, Ninasakul S, Leelapat P, Tavanabutra S, et al. Nutritional factors and thalassemia major. Arch Dis Child 1996; 74: 224-227.
17. Peyman E, Samin A, Saeed G, Armin R. Growth impairment in beta-thalassemia major: The role or trace element deficiency and other potential factors. J Pediat Hematol/Oncol 2007; 29: 5-8.
18. De-Sanctis V, Vullo C, Bagni B, Chiocoli L. Hypoparathyroidism in beta thalassemia major: Clinical and laboratory observations in 24 patients. Acta Haematol 1992; 88: 105-108.
19. Marcus N, Garty BZ. Transiet hypoparathyroidism due to amphotericin B-induced hypomagnesemia in a patient with beta-thalassemia. Ann Pharmacother 2001; 35: 1042-1044.
20. Burtis WJ. Parathyroid hormone-related protein: Structure Function and measurement. Clin Chem 1992; 38: 2171-2183.
21. Gertner JM. Disorders of calcium and Phosphorus homeostasis. Pediatr Clin North Am 1990; 37: 1441-1465.
22. Aldudak B, Karabay Bayazir A, Noyan A, Ozel A, Anarat A, Sasmaz I, et al. Renal function in pediatric patients with beta-thalassemia major. Pediatr Nephrol 2000; 15: 109-112.
23. Joiner CH. Cation transport and volume regulation in sickle blood cells. Am J Physiol 1993; 264: S251-S270.
24. Milner BA, Whitesid PJ. Introduction to Atomic Absorption spectrophotometry. England: Pye Unicam LTD: 1989.
25. Milner BA, Whitesid PJ. Introduction to Atomic Absorption spectrophotometry. England: Pye Unicam LTD: 1989.
26. Pecsce AJ, Kaplan LA, editors. Method in clinical chemistry. USA: CV Mosby Co. Boston; 1987. p. 1038-1042.
27. Burts CA, Ashwood ER. Textbook of Clinical chemistry, 2nd ed. Philadelphia (PA): W.B. Saunders Company: 1997.
28. Consolini R, Calleri A, Legitimo A, Massei F. Immunological Evaluation of Patients with Beta-Thalassemia major. Acta Haematol 2001 105: 7-12.
29. Silprasert A, Laokuldilok T, Kulapongs P. Zinc deficiency in beta-thalassaemia children. In: Fuchamen S, Rowley PT, Paul NW, editors. Thalassemia pathophysiology and management. New York: Alan R Liss. Inc.; 1987. p. 473-476.
30. Beutler E, Felitti V, Gelbarr T, Ho N. Genetics of iron storage and hemochromatosis. Drug Metab Dispos 2001; 29: 495-499.
31. Aleem A, Al-Momen AK, Al-Harakati MS, Hassan A, Al-Fawaz I. Hypocakemia due to hypoparathymidism in beta-thalassemia major patients. Ann Saudi Med 2000; 20: 364-366.
32. Zafeiriou DI, Athanasiou M, Katzos G, Economou M. Kontopoulos E. Hypoparathroidism and intracranial calcifications in beta-thalassemia major. J Padiatr 2001; 138: 411.
33. Kontessis P, Mayopoulou-Symvoulidis D, Symvoulidis A, Kontopaulou-Griva I. Renal involvement in sickle cell-beta. thalassemia. Nephron 1992; 61: 10-15.
34. Praticò G, Di Gregorio F, Cahabiano L, Palano GM, Caruso-Nicoletti M. Calcium phosphate metabolism in thalassemia. Pediatr Med Chir 1998; 20: 265-268.
35. Haslett CH, Chilvers ER, Hunter JA, Boon NA, editora. Davidson's principles and practice of medicina 18th ed. USA: Churchill Livingstone: 1999. p. 766-768.